Enjoying the #Optimizing_2022 congress today at @IMIM_research, Biomedicina BCN !!
Great talk by Noemi Reguart on moving IO to earlier stages in lung cancer 👩🔬👩🔬
Thank you @arriola_edurne and joaquim bellmunt for organizing
🔴 Just out of the oven, our review on ➡️Acquired Mechanisms of Resistance to Osimertinib—The Next Challenge @arriola_edurne Laura Moliner mdpi.com/1583386 via Cancers MDPI
Incredible start to day 2 at #ESMOacademy22 with d.planchard @arriola_edurne and Anne-Marie Dingemans giving the whistle-stop tour of lung cancer, covering NSCLC stage I-IV and SCLC in 100 minutes!
2/ Huge thanks to our #mentors & institutes - part of the 2021 Research #ESMOFellowship programme 🙌 ow.ly/j6GQ50G5mSe
Eric Deutsch @arriola_edurne Team McNeish Lab Benjamin Besse Christos Sotiriou CRUK Lung Centre Joaquin Mateo Rodrigo Dienstmann_MD_MBA Andrea Necchi UBAonline Instituto de Cálculo Vall d’Hebron Institute of Oncology (VHIO)
Christian Rolfo Benjamin Besse @arriola_edurne @IMIM_research OncoAlert Gustave Roussy The list may become very long (or the slide too busy). I am sure he mentioned the recent work on acetaminophen
dailynews.ascopubs.org/do/10.1200/ADN…
🎬We're back on track with BITE3‼️ Today we are talking about #immunotherapy and targeted therapies in #lungcancer #brainmetastasis with Noelia Vilariño and @arriola_edurne 👩🔬👩⚕️
Check out our content👉 scientificbites.com
Hospital del Mar IDIBELL Hospital Universitari Bellvitge | HUB
Great conference by Marina Garassino about “the future of new therapies in locally-advanced unresectabe #NSCLC ” in #MPITT2021
Now time of discussion and questions with DOLORES ISLA and @arriola_edurne 🔝
📌 Great lectures on localized #NCLC by d.planchard and #SCLC by @arriola_edurne at #ESMOacademy22 ESMO - Eur. Oncology
✔️ Adjuvant CDDP-based CT
✔️Neoadjuvant NADIM II
✔️ Adjuvant INPOWER-10,ADAURA
✔️CT-RT + Durvalumab PACIFIC
✅ Concurrent CT/RT
✅CT+IO CASPIAN/IMP-133
#lungcancer #oncology
Fascinada por la presentación de @arriola_edurne en #forodebateoncología sobre la app trialing.org diseñada junto a Max Hardy-Werbin para localizar ensayos clínicos de pulmón, que próximamente expandirán al resto de tumores, en España y así derivar pacientes candidatos.
Really excited for participating in the Optimizing Immunotherapy Hybrid Congress @IMIM_research Thanks for the invitation and organization @arriola_edurne joaquim bellmunt
Benjamin Besse giving important insights on how we can improve clinical trials design with new stratification factors to select better responders to IO treatment.Optimizing
Immunotherapy Congress, Barcelona 🇪🇺 @arriola_edurne @IMIM_research OncoAlert Gustave Roussy
Noemi Reguart Hospital Clínic @JanssenESP Víctor Albarrán-Artahona charocampelo @arriola_edurne Cristina Teixidó Jordi Remon Laura Mezquita Com m'han agradat sempre els coding lung cancer! Vindrem!
🔊El GECP, junto a Janssen, ha otorgado tres becas de investigación en #cancerdepulmon de 90.000 euros. ➡️Se han concedido a las doctoras, Noemi Reguart , del Hospital Clínic de Barcelona, @arriola_edurne , del Hospital del Mar y Ana Blasco, del HOSPITAL GENERAL
Noemi Reguart Marina Garassino Tactics Ernest Nadal Enriqueta Felip @arriola_edurne Jordi Remon Lara Pijuan,MD PhD Marga Majem Congrats Noeeeeee! you always going further!